CD32 captures committed haemogenic endothelial cells during human embryonic development.
Nat Cell Biol
; 26(5): 719-730, 2024 May.
Article
em En
| MEDLINE
| ID: mdl-38594587
ABSTRACT
During embryonic development, blood cells emerge from specialized endothelial cells, named haemogenic endothelial cells (HECs). As HECs are rare and only transiently found in early developing embryos, it remains difficult to distinguish them from endothelial cells. Here we performed transcriptomic analysis of 28- to 32-day human embryos and observed that the expression of Fc receptor CD32 (FCGR2B) is highly enriched in the endothelial cell population that contains HECs. Functional analyses using human embryonic and human pluripotent stem cell-derived endothelial cells revealed that robust multilineage haematopoietic potential is harboured within CD32+ endothelial cells and showed that 90% of CD32+ endothelial cells are bona fide HECs. Remarkably, these analyses indicated that HECs progress through different states, culminating in FCGR2B expression, at which point cells are irreversibly committed to a haematopoietic fate. These findings provide a precise method for isolating HECs from human embryos and human pluripotent stem cell cultures, thus allowing the efficient generation of haematopoietic cells in vitro.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Receptores de IgG
/
Desenvolvimento Embrionário
/
Hematopoese
Limite:
Humans
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article